3-year-old girl dies after possible drowning at Eagle Mountain Lake, officials say
Authorities were called to the scene around 4:30 p.m. Thursday. Deputies found the child on the ground after she had been pulled from the lake. She was transported to a local hospital, where she was pronounced dead.
Investigators are working to determine how the child entered the water. The Tarrant County Medical Examiner will determine the official cause of death.
CBS News Texas will provide updates as more information becomes available.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
A hiker died picking up this creature. What to do if you encounter one
A hiker in a Tennessee state park died recently after picking up a rattlesnake that bit him on the hand. The hiker, a man whose name was not released, was in Savage Gulf State Park in Gruetli-Laager, Tennessee, around 12:30 p.m. on Aug. 8, Matthew Griffith, director for the Grundy County Emergency Association, said in an email to The New York Times. A witness told officials that the hiker had picked up a snake, which was believed to be a timber rattlesnake, and was bitten on a hand, Griffith said. It was not clear why the hiker picked up the snake. Emergency medical workers arrived and performed CPR but the man died at the hospital. How common are rattlesnake bites? Rattlesnake bites in the U.S. range from 7,000 to 8,000 annually, with most bites occurring in the South, according to According to the foundation, states with the highest incidence of snake bites per million population per year are: North Carolina at 157.8 West Virginia at 105.3 Arkansas at 92.9 Oklahoma at 61, Virginia a48.7 Texas at 44.2. Rattlesnakes are active from April to October depending on the region of the country in which they live. They're found across much of the United States but are especially common in the Southwest. Arizona has more types of rattlesnakes than any other state, followed by California, Texas, New Mexico and Utah, according to Rattlesnakes are not found in Alaska, Hawaii, Maine and Rhode Island. Like most snakes, rattlers prefer warm, sunny weather and dense vegetation. They live in deserts, mountainous regions, forests and prairies. Rattlesnakes are carnivores that eat mice, voles, chipmunks and other small mammals. A rattlesnake warning Officials in Draper, Utah, recently posted a rattlesnake warning on Facebook. Sightings were reported near the Coyote Hollow Trailhead and the Mercer Hollow area of SunCrest. 'Snakes may be coming into more populated areas due to dry conditions. Be especially careful around ponds and air conditioning units,' according to the post. There are five rattlesnake species in Utah, and the most common is the Great Basin rattlesnake, which is a subspecies of the Western rattlesnake, according to the state Division of Wildlife Resources. Rocky benches, high-elevation slopes and dry canyons are the most common places in Utah to encounter rattlesnakes, often while people are out hiking, rock climbing or biking, per Wildlife Resources. However, you might also come across rattlers at lower elevations and in open areas. Individual rattlesnakes move around a large area known as their 'home range' and will usually move on from a specific location within a short period of time, according to Wildlife Resources. Rattlesnakes are protected under Utah law, making it illegal to harass or kill one. They use their venom to subdue prey so they can eat it, and a snake will only bite defensively if it feels threatened. 'Like most wild animals, rattlesnakes fear humans and will do anything they can to avoid us,' according to Wildlife Resources native herpetology coordinator Alyssa Hoekstra. 'If a snake is feeling threatened, it may act in defense. The best course of action is to maintain a safe distance from rattlesnakes and other native snake species.' What to do if you encounter a rattlesnake Utah Wildlife Resources offers these tips to stay safe: Remain calm and stay at least 10 feet from the snake. Make sure to give it plenty of space. If the snake is in the middle of the trail, step off the trail and go around it. Do not try to kill the snake. Doing so is illegal and greatly increases the chance that the snake will bite you. Do not throw anything at the snake (rocks, sticks, etc.). Rattlesnakes may move toward you as they attempt to flee. Alert other people to the snake's location. Advise them to use caution and to avoid getting close to the snake. Keep children and pets away. If you hear a rattle, try to locate where the sound is coming from before you react, so you don't step closer to the snake or on top of it. Solve the daily Crossword
Yahoo
4 minutes ago
- Yahoo
Penumbra, Inc. to Present at Upcoming Investor Conferences
ALAMEDA, Calif., Aug. 20, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following investor conferences on the dates and times listed below. Event: 2025 Wells Fargo Healthcare Conference Date: Wednesday, September 3, 2025 Time: 8:45am ET/5:45am PT Event: Morgan Stanley 23rd Annual Global Healthcare Conference Date: Tuesday, September 9, 2025 Time: 1:50pm ET/10:50am PT Webcasts of the presentations can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at The webcasts will be available on the company's website for at least two weeks following each event. About Penumbra Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit and connect on Instagram, LinkedIn and X. Investor RelationsPenumbra, View original content to download multimedia: SOURCE Penumbra, Inc. Sign in to access your portfolio
Yahoo
4 minutes ago
- Yahoo
Exclusive-CVS holds off adding Gilead's new HIV prevention shot to drug coverage lists
By Deena Beasley (Reuters) -CVS Health, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the medicine's proven effectiveness. CVS based the decision on clinical, financial, and regulatory factors, spokesperson David Whitrap said in an email. It also will not cover Yeztugo under its Affordable Care Act formularies, since its ACA preventive program follows recommendations and mandates from the U.S. Department of Health and Human Services (HHS), Whitrap said. Current HIV prevention recommendations from the U.S. Preventive Services Task Force (USPSTF), which is supported by HHS, include only three older drugs. A source familiar with the situation suggested that Gilead is still negotiating with CVS over Yeztugo, a twice-yearly injection with a U.S. list price of more than $28,000 a year. The decision by CVS is "a grave disappointment and frankly a missed opportunity," said Mitchell Warren, executive director of the AIDS nonprofit AVAC. "It does reflect a price that is too high and a U.S. pharmaceutical pricing structure that is frankly not sustainable." He and other AIDS activists have said Yeztugo could be a transformative tool in ending the 44-year-old epidemic that infects 1.3 million people a year and is estimated by the World Health Organization to have killed more than 42 million. Pharmacy benefit managers, or PBMs, act as middlemen between drug companies and consumers. They negotiate volume discounts with drug manufacturers on behalf of employers and health plans based on coverage terms. The three largest - CVS Caremark, UnitedHealth Group's OptumRX and Cigna's Express Scripts - control about 70% of specialty drug prescriptions in the U.S. Optum said Yeztugo will be reviewed for coverage in the coming weeks, while Express Scripts did not respond to requests for comment. Gilead, which declined to comment, said earlier this month it is on track to secure 75% U.S. insurer coverage of Yeztugo by year-end and 90% coverage by June 2026. Its CEO, Daniel O'Day, has said that half of every dollar spent on medicines in the U.S. goes to PBMs and other entities that do not make drugs. U.S. government healthcare programs, including the Veterans Administration and the Medicare program for people over age 65, have already added Yeztugo to coverage lists. Gilead said earlier this month that several state-run Medicaid plans, including California and New York, were covering the drug. Gilead, its investors, and AIDS activists have high hopes for Yeztugo. Approved in June for people at high risk of HIV, the drug was shown to be nearly 100% effective at preventing infection in large trials, fueling fresh optimism about limiting the spread of HIV. Some analysts have warned that a recent Supreme Court ruling affirming broad HHS authority over the USPSTF could affect coverage prospects while Robert F. Kennedy Jr is in charge of the agency. Medical groups have expressed alarm about reports that Kennedy could replace members of the task force. The 16-member task force reviews evidence and public input, then recommends preventive services that catch disease early or prevent worsening, which insurers must cover without patient cost-sharing. For HIV prevention, it endorses daily PrEP pills Truvada, which is available as a generic, and Gilead's Descovy, as well as ViiV Healthcare's bimonthly shot Apretude. Gilead's O'Day has stressed that the lifetime cost of treating an HIV patient can exceed $1 million, making a preventive treatment cost effective. (Reporting By Deena Beasley; Editing by Patrick Wingrove and Diane Craft) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
